Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zimmerman

Showing results (791-800 of 915) with videos related to

Pageof 92
Sort By:
Journal of Hematotherapy|December 1, 1995
Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safetyT M Zimmerman, S F Williams, J G Bender, et al.
BMC Cancer|February 10, 2011
Mutational profiling reveals PIK3CA mutations in gallbladder carcinomaVikram Deshpande, Afamefuna Nduaguba, Stephanie M Zimmerman, et al.
Clinical and Vaccine Immunology : CVI|January 16, 2009
Safety and immunogenicity of the Mycobacterium tuberculosis DeltalysA DeltapanCD vaccine in domestic cats infected with feline immunodeficiency virusDawn M Zimmerman, W Ray Waters, Konstantin P Lyashchenko, et al.
Journal of the American Academy of Dermatology|November 13, 2019
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Patient Preference and Adherence|March 27, 2020
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or AdalimumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
American Journal of Primatology|April 7, 2022
Great ape health watch: Enhancing surveillance for emerging infectious diseases in great apesDawn M Zimmerman, Stephanie L Mitchell, Tiffany M Wolf, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or AdalimumabAndrew Blauvelt, Nianwen Shi, Baojin Zhu, et al.
Leukemia & Lymphoma|April 18, 2009
Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myelomaAsher A Chanan-Khan, Ruben Niesvizky, Raymond J Hohl, et al.
Antiviral Research|June 17, 2026
BDAA, a yellow fever virus NS4B inhibitor, is effective during therapeutic treatment in a hamster model of yellow feverAbbie E Weight, Arnaud J Van Wettere, Shawn M Zimmerman, et al.
Journal of Medicinal Chemistry|September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6B E Cantrell, D M Zimmerman, J A Monn, et al.
Pageof 92

Showing results (791-800 of 915) with videos related to

Sort By:
Pageof 92
Journal of Hematotherapy|December 1, 1995
Clinical use of selected and expanded peripheral blood CD34+ cells: a preliminary report of feasibility and safetyT M Zimmerman, S F Williams, J G Bender, et al.
BMC Cancer|February 10, 2011
Mutational profiling reveals PIK3CA mutations in gallbladder carcinomaVikram Deshpande, Afamefuna Nduaguba, Stephanie M Zimmerman, et al.
Clinical and Vaccine Immunology : CVI|January 16, 2009
Safety and immunogenicity of the Mycobacterium tuberculosis DeltalysA DeltapanCD vaccine in domestic cats infected with feline immunodeficiency virusDawn M Zimmerman, W Ray Waters, Konstantin P Lyashchenko, et al.
Journal of the American Academy of Dermatology|November 13, 2019
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Patient Preference and Adherence|March 27, 2020
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or AdalimumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
American Journal of Primatology|April 7, 2022
Great ape health watch: Enhancing surveillance for emerging infectious diseases in great apesDawn M Zimmerman, Stephanie L Mitchell, Tiffany M Wolf, et al.
Journal of Managed Care & Specialty Pharmacy|November 29, 2019
Comparison of Health Care Costs Among Patients with Psoriasis Initiating Ixekizumab, Secukinumab, or AdalimumabAndrew Blauvelt, Nianwen Shi, Baojin Zhu, et al.
Leukemia & Lymphoma|April 18, 2009
Phase III randomised study of dexamethasone with or without oblimersen sodium for patients with advanced multiple myelomaAsher A Chanan-Khan, Ruben Niesvizky, Raymond J Hohl, et al.
Antiviral Research|June 17, 2026
BDAA, a yellow fever virus NS4B inhibitor, is effective during therapeutic treatment in a hamster model of yellow feverAbbie E Weight, Arnaud J Van Wettere, Shawn M Zimmerman, et al.
Journal of Medicinal Chemistry|September 13, 1996
Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6B E Cantrell, D M Zimmerman, J A Monn, et al.
Pageof 92